Showing 1 - 10 of 26
The ageing process in OECD countries calls for a better understanding of the future disease prevalence, life expectancy and patterns of inequalities in health outcomes. In this paper we present the results obtained from several dynamic microsimulation models of the Future Elderly Model (FEM)...
Persistent link: https://www.econbiz.de/10014089895
Persistent link: https://www.econbiz.de/10012489038
Persistent link: https://www.econbiz.de/10013186895
Since the seminal paper by Ruhm (2000), a large body of literature agrees on the existence of pro-cyclical fluctuation between economy's performance and mortality, and this evidence has been confirmed also during the Great Recession (GR). In this study we identify a series of important...
Persistent link: https://www.econbiz.de/10012926157
Medical utilization, such as a count of hospitalizations, is routinely used as a health proxy for both policy and research purposes. Over time, trends in how medicine is practiced has impacted this relationship, as technological improvements or policy changes have altered hospitalizations at the...
Persistent link: https://www.econbiz.de/10012868558
Persistent link: https://www.econbiz.de/10011656180
Persistent link: https://www.econbiz.de/10011735248
Older Americans have experienced dramatic gains in life expectancy in recent decades, but an emerging literature reveals that these gains are accumulating mostly to those at the top of the income distribution. We explore how growing inequality in life expectancy affects lifetime benefits from...
Persistent link: https://www.econbiz.de/10012455352
Older Americans have experienced dramatic gains in life expectancy in recent decades, but an emerging literature reveals that these gains are accumulating mostly to those at the top of the income distribution. We explore how growing inequality in life expectancy affects lifetime benefits from...
Persistent link: https://www.econbiz.de/10012958580
A large body of literature, mainly based on hospital costs, shows that time to death (TTD) is by far a better predictor of health spending than age. In this paper, we investigate if this finding holds true also in presence of outpatient costs (drugs, diagnostic tests and specialist visits). Our...
Persistent link: https://www.econbiz.de/10013064401